Lawrenceville, NJ, United States of America

Michael Graeber

This inventor holds 30 USPTO granted patents and 32 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Dermatological Treatments. Top assignees: Galderma Research & Development, Galderma Laboratories Inc., Galderma S.a.. Active years: 2009-2019.

USPTO Granted Patents = 30 (Patent Applications = 32)

% Patents Active = 70.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 117(Granted Patents)

Company Filing History:

17 out of 222

Galderma Research & Development

patents

6 out of 27

Galderma Laboratories Inc.

Galderma Research & Development Snc

patents

5. 1 out of 1

Gladerma Research & Development Snc

patent

Years Active: 2009-2019

Loading Chart...

Areas of Expertise:

Ivermectin

Dermatological Disorders

Acne Treatment

Rosacea

Erythema

6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic Acid

Adapalene

Benzoyl Peroxide

Inflammatory Lesions

Skin Tumor

Topical Application

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10206939 - Treatment of papulopustular rosacea with ivermectin (2019-02-19),

2. 9901556 - Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders (2018-02-27),

3. 9872842 - Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders (2018-01-23),

4. 9861632 - Methods and compositions for safe and effective treatment of erythema (2018-01-09),

5. 9861631 - Methods and compositions for safe and effective treatment of erythema (2018-01-09),

6. 9782425 - Treatment of papulopustular rosacea with ivermectin (2017-10-10),

7. 9622994 - Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (2017-04-18),

8. 9554988 - Method for preventing or treating skin tumor (2017-01-31),

9. 9387187 - Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders (2016-07-12),

10. 9381179 - Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders (2016-07-05),

11. D758048 - Garment (2016-06-07),

12. 9233118 - Treatment of papulopustular rosacea with ivermectin (2016-01-12),

13. 9233117 - Treatment of inflammatory lesions of rosacea with ivermectin (2016-01-12),

14. 8921423 - Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (2014-12-30),

15. 8916562 - Methods and compositions for safe and effective treatment of telangiectasia (2014-12-23),

Title: The Innovative Journey of Michael Graeber

Introduction: Michael Graeber, a talented inventor hailing from Lawrenceville, NJ, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Michael Graeber's latest patents include cutting-edge advancements in renewable energy technology, artificial intelligence systems, and sustainable materials.

Career Highlights: With a career spanning over two decades, Michael Graeber has worked for renowned tech companies, leading research institutions, and universities, where he has spearheaded numerous projects that have revolutionized various industries.

Collaborations: Throughout his career, Michael Graeber has collaborated with top-notch engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Michael Graeber's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the field of inventions.